A FORECAST ON THE 2024 CGTX LANDSCAPE

Moderator:
Anshul Mangal, President, Project Farma and Precision ADVANCE
Speakers:
Igor Bilinsky, Ph.D., Chief Operating Officer, Iovance Biotherapeutics
Phil Cyr, Senior Vice President, Precision Value & Health
Doug Danison, Head of Commercial, Cell and Gene Therapy Unit, Bayer
Stefan Irion, M.D., Chief Scientific Officer, BlueRock Therapeutics
Helen Sabzevari, Ph.D., President and CEO, Precigen